Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06115551 · ClinicalTrials.gov registry record · NA

Fasting Mimicking Diet and Autophagy

A NA study of Diet and Autophagy, sponsored by L-Nutra.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06115551: Active NA study of Diet and Autophagy, sponsored by L-Nutra.

NCT06115551 is a NA study of Diet and Autophagy that is active but no longer recruiting, run by L-Nutra. The registered enrollment target is 30 participants, below the 434-participant average among 17 other Diet trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06115551, a NA study of Diet and Autophagy, is active but no longer recruiting, sponsored by L-Nutra.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluates autophagy in circulating white blood cells from generally healthy human volunteers exposed to fasting mimicking diet (FMD), a 5-day dietary regimen.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT Fasting Mimicking Diet

Study Locations (1)

Texas

  • The University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-05-02
Est. Completion 2024-04-30
Phase NA
L-Nutra

5 total trials

What the registry record for NCT06115551 still lists

NCT06115551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 434-participant average among 17 other Diet trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Diet appearing as the primary indexed condition, and to 1 intervention - of which Fasting Mimicking Diet is the first listed.

NCT06115551 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06115551 about?

NCT06115551 is a clinical study titled "Fasting Mimicking Diet and Autophagy". This study aims to evaluates autophagy in circulating white blood cells from generally healthy human volunteers exposed to fasting mimicking diet (FMD), a 5-day dietary regimen.

What is the current status of trial NCT06115551?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-02. Estimated completion is 2024-04-30.

What conditions does trial NCT06115551 study?

This clinical trial studies the following conditions: Diet, Autophagy.

What interventions are being tested in trial NCT06115551?

The interventions under investigation include: Fasting Mimicking Diet (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06115551?

This trial is sponsored by L-Nutra, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06115551 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06115551's enrollment target sits among peer trials

30 14th of 17 higher than 4 of 17 other Diet trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06115551, the US trial registry maintained by the National Library of Medicine. NCT06115551 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.